Loading

Weekly Newsletter

Friday, November 7, 2025

News

Unveiling a Substantial Attempt to Shakeup the Biopharma Space for Good

TetraScience, the Scientific Data and AI Company, has officially announced the launch of its Scientific AI Lighthouse (SAIL) program with Takeda as founding partner. According to certain reports, this particular program arrives bearing a new model which, on its part,...

Ending a 20-year Old Wait for One Dedicated Antiviral Candidate

Genentech, a member of the Roche Group, had officially announced the launch of its Direct-to-Patient (DTP) program, which applies to Xofluza® (baloxavir marboxil), a single-dose oral antiviral medication used to treat the flu in patients aged five and up,...

A Closer Look at the Barriers Hampering the Health of Medicare-eligible Population

SelectQuote, Inc., a leading distributor of Medicare insurance policies and owner of a rapidly-growing healthcare services platform, has officially published the results from its latest report, which offers in-depth insights into the complex medical and social needs of the...

A Distinctive Play to Inform Drug Discovery and Validation Like Never Before

Genomics, a science-led tech-bio company using large-scale genetic information to develop innovative precision healthcare tools and to accelerate drug discovery and development, has officially announced the launch of Mystra, which happens to be the world's first ever original AI-enabled...

Innovators

Unveiling a Substantial Attempt to Shakeup the Biopharma Space for Good

TetraScience, the Scientific Data and AI Company, has officially announced the launch of its Scientific AI Lighthouse (SAIL) program with Takeda as founding partner. According to certain reports, this particular program arrives bearing a new model which, on its part,...

Ending a 20-year Old Wait for One Dedicated Antiviral Candidate

Genentech, a member of the Roche Group, had officially announced the launch of its Direct-to-Patient (DTP) program, which applies to Xofluza® (baloxavir marboxil), a single-dose oral antiviral medication used to treat the flu in patients aged five and up,...

A Closer Look at the Barriers Hampering the Health of Medicare-eligible Population

SelectQuote, Inc., a leading distributor of Medicare insurance policies and owner of a rapidly-growing healthcare services platform, has officially published the results from its latest report, which offers in-depth insights into the complex medical and social needs of the...

A Distinctive Play to Inform Drug Discovery and Validation Like Never Before

Genomics, a science-led tech-bio company using large-scale genetic information to develop innovative precision healthcare tools and to accelerate drug discovery and development, has officially announced the launch of Mystra, which happens to be the world's first ever original AI-enabled...

Insights

Unveiling a Substantial Attempt to Shakeup the Biopharma Space for Good

TetraScience, the Scientific Data and AI Company, has officially announced the launch of its Scientific AI Lighthouse (SAIL) program with Takeda as founding partner. According to certain reports, this particular program arrives bearing a new model which, on its part,...

Ending a 20-year Old Wait for One Dedicated Antiviral Candidate

Genentech, a member of the Roche Group, had officially announced the launch of its Direct-to-Patient (DTP) program, which applies to Xofluza® (baloxavir marboxil), a single-dose oral antiviral medication used to treat the flu in patients aged five and up,...

A Closer Look at the Barriers Hampering the Health of Medicare-eligible Population

SelectQuote, Inc., a leading distributor of Medicare insurance policies and owner of a rapidly-growing healthcare services platform, has officially published the results from its latest report, which offers in-depth insights into the complex medical and social needs of the...

A Distinctive Play to Inform Drug Discovery and Validation Like Never Before

Genomics, a science-led tech-bio company using large-scale genetic information to develop innovative precision healthcare tools and to accelerate drug discovery and development, has officially announced the launch of Mystra, which happens to be the world's first ever original AI-enabled...